Adienne Pharma & Biotech Is A Biopharmaceutical Group Based In Luganoswitzerlandwith Origins In Italyfounded In 2004The Company Focuses On Developing Treatments For Rare And Severe Diseasesparticularly In Hematology And Immunologyadienne Is Recognized For Its Innovative Solutions In Areas Such As Haemato Oncologyhematopoietic Stem Cell Transplantationsolid Organ Transplantationand Autoimmune Diseases The Company Specializes In Supporting Hospital Pharmacistsparticularly With Cytotoxic Oncology Drugsadienne Has Developed Single Use Technologies For Manufacturing Biological Drugs And Holds Patents For Preparing Cytotoxic Drugs In Ready To Use Multi Chamber Bagsthis Technology Improves Drug Stability And Simplifies Handlingpotentially Allowing For Home Administration Of Some Oncology Treatmentsadienne S Product Portfolio Includes Orphan Designated Medicinal Products And A Monoclonal Antibody For Treating Acute Graft Versus Host Diseasewhich Has Completed Phase Ii Clinical Development Adienne Operates Gmp Facilities For Producing Sterile Biotechnological Products And Has Received Authorizations For Various Drug Presentationsthe Company Collaborates With Universities And Hospitals To Advance Drug Development And Aims To Enhance Treatment Accessibility For Oncology Patients Through Its Innovative Formulations
